Steven Gillis's Net Worth

$317 Thousand

Who is Steven Gillis?

Steven Gillis does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., VBI VACCINES INC., PHASERX, INC., Neumora Therapeutics, Inc., Trubion Pharmaceuticals, Inc, VBI Vaccines Inc/BC, DA32 Life Science Tech Acquisition Corp., Erasca, Inc., Pulmatrix, Inc., Verve Therapeutics, Inc., bluebird bio, Inc., Codiak BioSciences, Inc., Sienna Biopharmaceuticals, Inc., Homology Medicines, Inc., Prime Medicine, Inc., CORIXA CORP, Boundless Bio, Inc., and Rapport Therapeutics, Inc..

SEC CIK

Steven Gillis's CIK is 0001229592

Past Insider Trading and Trends

2020 was Steven Gillis's most active year for acquiring shares with 13 total transactions. Steven Gillis's most active month to acquire stocks was the month of May. 2005 was Steven Gillis's most active year for disposing of shares, totalling 22 transactions. Steven Gillis's most active month to dispose stocks was the month of June. 2005 saw Steven Gillis paying a total of $1,278,635.97 for 320,673 shares, this is the most they've acquired in one year. In 2005 Steven Gillis cashed out on 1,043,560 shares for a total of $1,626,411.60, their largest year based on trade value.